PDB23 SWITCHING TO INSULIN DEGLUDEC IS A COST-SAVING THERAPY FOR PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES IN THE SWEDISH SETTING BASED ON REAL WORLD DATA
Abstract
Authors
J. Jendle M. Thunander B. Ekman S. Sjöberg Å. Ericsson J. da Rocha Fernandes A.C. Mårdby S.J.P. Malkin B. Hunt